newsfilter
← Latest News
GlobeNewswire·

Immuneering Appoints Dr. Thomas Schall as Chairman of the Board

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ:IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the appointment of Thomas J. Schall,